The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a Southwest Oncology group study

Two hundred and ninety‐eight patients with limited (confined to chest and supraclavicular area, encompassable by a single radiation portal) small cell carcinoma of the lung were entered on Southwest Oncology Group Protocol 7628. Patients were treated with multi‐agent chemotherapy and radiation therapy with or without BCG. Radiation therapy quality control analysis, including dosimetric reconstruction and port film review was introduced after the protocol was activated and was retrospectively applied. Patients who were considered major protocol variations had statistically worse survival (40 weeks versus 60 weeks; P = 0.002), a lesser improvement in response rate after induction chemotherapy (27 versus 48%; P = 0.05) and a higher chest failure rate (77 versus 55%; P = 0.047) than evaluable patients. Five patients relapsed in the brain, all associated with chest failure. Quality control is essential in cooperative group studies.

[1]  R. Carey,et al.  Small cell anaplastic carcinoma of lung. Reappraisal of current management , 1976, Cancer.

[2]  R. Weiss.  Small-cell carcinoma of the lung: therapeutic management. , 1978, Annals of internal medicine.

[3]  R. Livingston,et al.  The effectiveness of prophylactic brain irradiation in small cell carcinoma of the lung. A Southwest Oncology Group Study , 1978, Cancer.

[4]  C. Perez,et al.  Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: A randomized prospective study by the southeastern cancer study group , 1981, Cancer.

[5]  F. Hirsch,et al.  Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination. , 1978, Annals of internal medicine.

[6]  R. Wittes,et al.  Oat cell carcinoma of the lung. , 1975, Clinical bulletin.

[7]  C. Perez,et al.  Preliminary report of a cooperative randomized study for the treatment of localized small cell lung carcinoma. , 1979, International journal of radiation oncology, biology, physics.

[8]  T. Mcelwain,et al.  Combination chemotherapy for small cell carcinoma of the lung , 1977, Cancer.

[9]  C. Coltman,et al.  Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small‐cell carcinoma of the lung: A Southwest Oncology group study , 1982, Cancer.

[10]  H. Brereton,et al.  "Total" therapy for small cell carcinoma of the lung. , 1978, The Annals of thoracic surgery.

[11]  J. Cox,et al.  Dose-time relationships and the local control of small cell carcinoma of the lung. , 1978, Radiology.

[12]  M. Melamed,et al.  Oat cell carcinoma of the lung. Combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate , 1977, Cancer.

[13]  T. Pajak,et al.  A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy‐radiation therapy versus cyclophosphamide‐radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation , 1980, Cancer.

[14]  E. Glatstein,et al.  Role of radiation therapy in combination with chemotherapy in extensive oat cell cancer of the lung: a randomized study. , 1977, Cancer treatment reports.

[15]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[16]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[17]  H. Barkley,et al.  The role of radiation therapy in the treatment of small cell undifferentiated bronchogenic cancer. , 1979, International journal of radiation oncology, biology, physics.